Third Harmonic Bio Inc (THRD) - Market Value
The current price chart for Third Harmonic Bio (THRD) demonstrates the player's position in a fierce battle for leadership in allergy treatment, a sector dominated by corporate behemoths. The business relies on a streamlined express delivery system for test components, which ensures a stable income level of 0.24. Third Harmonic Bio (THRD) currently operates on external investments, as its primary products are still undergoing clinical trials and are not yet generating profit.
Comprehensive metric breakdowns and analytics for Third Harmonic Bio Inc (THRD)
- current price and projected stock value:
- market capitalization indicators:
- book value of equity indicators:
- debt and solvency information:
Total Debt to Capital Third Harmonic Bio|THRD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Third Harmonic Bio|THRD - Company Aggregate Debts|Debt to Book Capitalization Ratio Third Harmonic Bio Inc|THRD - Company Long-Term Loans and Borrowings|Company Short-Term Debt Third Harmonic Bio|Quick Ratio thirdharmonicbio.com
- financial results and valuation multiples details:
THRD - Net Profit|Future Profit Third Harmonic Bio|THRD - Company Value to Net Income|Forward P/E Multiple Third Harmonic Bio, Inc|THRD - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Third Harmonic Bio Inc|THRD - Operating profit before deduction of amortization|Earnings per share for the last twelve months Third Harmonic Bio|THRD - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months thirdharmonicbio.com|THRD - Earnings growth in current year|Net earnings per share growth forecast for next year Third Harmonic Bio
Fundamental company analysis:THRD (Third Harmonic Bio, Inc.)
Market capitalization is used to assess the scale of Third Harmonic Bio (THRD) within the anti-inflammatory sector. This market capitalization level is calculated as the product of the total number of shares and their current price. The metric objectifies the market consensus, filtering out emotional price fluctuations. For a biotech company, such a valuation reflects the monetization potential of its intellectual property. The high scalability of its developments allows for a rapid increase in business value with minimal expenditures.
Key competitors
Market Capitalization ARGX (argenx)|Market Value BNTX|ABVX - Market Value|Market Value ADMA (ADMA Corp)|PTGX: Market Capitalization|Market Capitalization IMVT|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT: Market Valuation|Aerovate Therapeutics Inc - Market Value|ACRS: Market Capitalization|kyvernatx.com - Market Value|TLSA (Tiziana Life Sciences Ltd) - Market Capitalization|Cabaletta Bio Inc. (CABA) - Market Capitalization|Market Value Ventyx Bio (VTYX)|THTX (Theratechnologies, Inc) - Market Value|Market Capitalization AVTX (Avalo Therapeutics, Inc)|ELDN: Market Capitalization|AGEN: Market Valuation|Market Value CLYM (Climb Bio Inc.)|ZURA: Market Capitalization|aTyr Pharmaceuticals - Market Value|ADAG (Adagene Inc) - Market Capitalization|Market Capitalization Ikena Oncology, Inc.|Market Value Shattuck Labs, Inc. (STTK)|EQ (equilliumbio.com) - Market Value|Market Value Connect Biopharma Holdings Limited CNTB|IMUX - Market Valuation|ATRA - Market Value|Market Value InflaRx N.V.|X4 Pharmaceuticals, Inc. (XFOR) - Market Value|Market Capitalization ACET|CELU (Celularity Inc) - Market Capitalization|INmune Bio Corporation (INMB) - Market Capitalization|Market Capitalization BRNS|Market Valuation kezarlifesciences.com KZR|SAB Biotherapeutics, Inc. - Market Valuation|Market Value AKTX|Enlivex Therapeutics, Ltd. - Market Capitalization|QTTB: Market Value|GOVX: Market Capitalization|EDSA - Market Capitalization|Market Value iBio|Market Value Carisma Tx CARM|Market Valuation XTLB (XTL Biopharmaceuticals, Ltd.)|Market Value BOLT|Market Capitalization HCWB (HCW Biologics)|Market Value APVO|AIM - Market Value|Market Value ADTX (Aditxt)|GRI: Market Capitalization|Market Capitalization XRTX|Market Value Vyome Holdings Inc|revbiosciences.com - Market Valuation|Market Capitalization INDP|SCNI (Scinai Immunotherapeutics Ltd) - Market Value|Market Capitalization CALI (CalciMedica)|Market Capitalization Affimed NV AFMD|ALLK - Market Value|Market Value HOOK (HOOKIPA Pharma Inc.)|igmbio.com (IGMS) - Market Value|Market Valuation iTeos Therapeutics Inc|OCEA (Ocean Bio) - Market Capitalization|Market Capitalization TC BioPharm Ltd
